Time to next treatment, healthcare resource utilization, and costs associated with ibrutinib use among US veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world retrospective analysis

Abstract Authors: Qing Huang, Sujana Borra, Jieni Li, Li Wang, Sulena Shrestha, Murali Sundaram, Nora Janjan  Background: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most common adult leukemia, accounting for ≈ 37% of all leukemias in the...

Evaluating the effect of treatment persistence on the economic burden of moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population

Abstract Authors: Lee S, Xie L, Wang Y, Vaidya N, Baser O. Background: Psoriasis is a chronic, hyper-proliferative dermatological condition associated with joint symptoms known as psoriatic arthritis (PsA). In a 2013 review, the total economic burden of PsA was...

Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the US Department of Defense Population

Abstract Authors: Lee S, Xie L, Wang Y, Vaidya N, Baser O. Background: Psoriasis is a chronic, hyper-proliferative dermatological condition associated with joint symptoms known as psoriatic arthritis (PsA). In a 2013 review, the total economic burden of PsA was...